发明名称 Benzoxazinone amides as mineralocorticoid receptor modulators
摘要 Disclosed are certain derivatives of benzoxazinone amides of formula (I), or pharmaceutically acceptable salts thereof,; that act as mineralocorticoid (MR) receptor modulators that may reduce oxidative stress in endothelium and hence improve vascular function, to methods for their potential therapeutic use, to pharmaceutical compositions containing them and to processes for preparing such compounds.
申请公布号 US9394291(B2) 申请公布日期 2016.07.19
申请号 US201514753239 申请日期 2015.06.29
申请人 AstraZeneca AB 发明人 O'Mahony Gavin;Kossenjans Michael;Edman Karl;Kajanus Johan;Hogner Karl Anders;Cornwall Philip;Turner Andrew
分类号 C07D413/10;C07D413/06;C07D265/36 主分类号 C07D413/10
代理机构 代理人
主权项 1. A compound of formula (I) wherein R1 is selected from CONH2 or CONHCH3; and R2 is selected from H, F, Cl or Br; or a pharmaceutically acceptable salt thereof.
地址 Sodertalje SE